Wnt‐β‐catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer

We determined the gene expression profiles for 48 ATP binding cassette (ABC) transporters in matched colon cancer and normal colon tissues in order to provide insight into the mechanisms underlying expression of transporters related to colon carcinogenesis. The expression of ABCB1, ABCC1, ABCC2, ABCC3, and ABCG2 was altered in association with colon carcinogenesis. Among these transporters, the expression of ABCC3 was repressed by Wnt signaling pathway in colon cancer cell lines. Knockdown of the pathway components transcription factor 7‐like 2 (TCF7L2) or β‐catenin thus increased ABCC3 expression, whereas activation of Wnt signaling with inhibitors of glycogen synthase kinase–3β (GSK‐3β) reduced it. ChIP and luciferase reporter assays also showed that TCF7L2 binds to the ABCC3 locus and regulates its expression. Finally, overexpression of ABCC3 in colon cancer cells conferred resistance to anticancer drug‐induced cytotoxicity. Our data thus suggest that Wnt signaling represses ABCC3 expression during colon carcinogenesis, and that subsequent upregulation of ABCC3 expression during drug treatment might contribute to acquired drug resistance.

• Publication year

  2016

• Venue

  Cancer Science

• Publication date

  2016-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cas.13097PMID 27709738PMCID 5198960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wnt‐β‐catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer

  2016cited by this paper
• TCF/LEF Transcription Factors: An Update from the Internet Resources

  2016cited by this paper
• The mechanisms of genome-wide target gene regulation by TCF7L2 in liver cells

  2014cited by this paper
• Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway.

  2014cited by this paper
• Integrative ChIP-seq/Microarray Analysis Identifies a CTNNB1 Target Signature Enriched in Intestinal Stem Cells and Colon Cancer

  2014cited by this paper
• Differential Regulation of EGFR–MAPK Signaling by Deoxycholic Acid (DCA) and Ursodeoxycholic Acid (UDCA) in Colon Cancer

  2014cited by this paper
• Ras-Induced Changes in H3K27me3 Occur after Those in Transcriptional Activity

  2013cited by this paper
• Molecularly targeted drugs for metastatic colorectal cancer

  2013cited by this paper
• Molecular Pathways Molecular Pathways : Regulation and Therapeutic Implications of Multidrug Resistance

  2012cited by this paper
• Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3

  2012cited by this paper
• The role of ABC transporters in progression and clinical outcome of colorectal cancer.

  2012cited by this paper
• Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq

  2010cited by this paper
• Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer

  2009cited by this paper
• Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.

  2009cited by this paper
• Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

  2006cited by this paper
• The price tag on progress--chemotherapy for colorectal cancer.

  2004cited by this paper
• Tissue Distribution and Induction of Human Multidrug Resistant Protein 3

  2002cited by this paper
• Multidrug resistance in cancer: role of ATP–dependent transporters

  2002cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR).

  2000cited by this paper
• CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR.

  1999cited by this paper
• MRP3, an organic anion transporter able to transport anti-cancer drugs.

  1999cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper

• Polystyrene microplastics induce liver fibrosis and lipid deposition in mice through three hub genes revealed by the RNA-seq

  2025cites this paper
• Critical Contribution of Various Signaling Pathways in the Development of Drug Resistance in Colorectal Cancer: An Update

  2025cites this paper
• Strategies for overcoming ABC transporter mediated drug resistance in colorectal cancer.

  2025cites this paper
• Predicting Treatment Outcomes in Glioblastoma: A Risk Score Model for TMZ Resistance and Immune Checkpoint Inhibition

  2025cites this paper
• ABCC3 Is a Differential Marker of CYP11B2-Negative Zona Glomerulosa Cells in Human Adrenal Cortex

  2025cites this paper
• PMF-GRN: a variational inference approach to single-cell gene regulatory network inference using probabilistic matrix factorization

  2024cites this paper
• The association of ABC proteins with multidrug resistance in cancer.

  2024cites this paper
• Exploring Bile Acid Transporters As Key Players In Cancer Development And Treatment: Evidence From Preclinical And Clinical Studies.

  2024cites this paper
• Downregulation of ABCC3 activates MAPK signaling through accumulation of deoxycholic acid in colorectal cancer cells

  2024cites this paper
• FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma

  2022cites this paper
• HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3.

  2022cites this paper
• Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer

  2022cites this paper
• Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers

  2022cites this paper
• Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers

  2022cites this paper
• Genetic and pharmacologic suppression of PPARγ enhances NELL-1-stimulated bone regeneration.

  2022cites this paper
• Polyphyllin VII, a novel moesin inhibitor, suppresses cell growth and overcomes bortezomib resistance in multiple myeloma.

  2022cites this paper
• Role of multidrug resistance-associated proteins in cancer therapeutics: past, present, and future perspectives

  2021cites this paper
• BZD9L1 sirtuin inhibitor: Identification of key molecular targets and their biological functions in HCT116 colorectal cancer cells.

  2021cites this paper
• Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer

  2021cites this paper
• Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition

  2021cites this paper
• The implications of ABCC3 in cancer drug resistance: can we use it as a therapeutic target?

  2021cites this paper
• A Phenylfurocoumarin Derivative Reverses ABCG2-Mediated Multidrug Resistance In Vitro and In Vivo

  2021cites this paper
• The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues

  2021cites this paper
• Role of ATP-binding cassette transporters in cancer initiation and progression.

  2020cites this paper
• Discovery of a potent β-catenin destabilizer for overcoming the resistance of 5-fluorouracil in colorectal cancer.

  2020cites this paper
• Drug transporters in the development of multidrug resistance in colorectal cancer

  2020cites this paper
• Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment

  2020cites this paper
• MicroRNAs and colorectal cancer chemoresistance: New solution for old problem.

  2020cites this paper
• Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells

  2020cites this paper
• In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma

  2020cites this paper
• Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy

  2020cites this paper
• Liver and gastrointestinal cancers

  2020cites this paper
• CLDN8 promotes colorectal cancer cell proliferation, migration, and invasion by activating MAPK/ERK signaling

  2019cites this paper
• SETDB1-mediated FosB regulation via ERK2 is associated with an increase in cell invasiveness during anticancer drug treatment of A549 human lung cancer cells.

  2018cites this paper
• Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal cancer

  2018cites this paper
• Novel Potent ABCB1 Modulator, Phenethylisoquinoline Alkaloid, Reverses Multidrug Resistance in Cancer Cell.

  2018cites this paper
• Protein‐arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination

  2017cites this paper
• Altered expression profiles of circular RNA in colorectal cancer tissues from patients with lung metastasis

  2017cites this paper
• MEK inhibitor, PD98059, promotes breast cancer cell migration by inducing β-catenin nuclear accumulation.

  2017cites this paper
• Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance–Linked ATP-Binding Cassette Transporter ABCG2

  2017cites this paper
• Circular RNAs: Regulators of Cancer-Related Signaling Pathways and Potential Diagnostic Biomarkers for Human Cancers

  2017cites this paper
• Wnt‐β‐catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer

  2016cites this paper